In vitro 3D assay to test angiogenic effects of human CD14+ monocytes seeded on macroporous PLGA/CaP polymers with a CaP nanostructured surface

被引:5
作者
Hiebl, B. [1 ]
Fuhrmann, R. [2 ]
Costa, M. E. V. [3 ]
Almeida, M. M. [3 ]
Franke, R. P. [1 ,2 ]
机构
[1] Charite, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany
[2] Univ Ulm, Dept Biomat, Cent Inst Biomed Engn, D-89081 Ulm, Germany
[3] Univ Aveiro, Inst Ceram & Glass Engn, P-3810193 Aveiro, Portugal
关键词
D O I
10.3233/CH-2008-1061
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In this study we present a three-dimensional angiogenesis assay in vitro that allows the evaluation of the influence of Poly(lactic-co-glycolic acid) based implants seeded with VEGF-A165 stimulated/activated human CD14+ monocytes on the attraction and migration of human micro vascular endothelial cells (HMVEC-L). Primary HMEC of the capillary bed were cultured on an extracellular matrix generated by bovine corneal endothelial cells (BCEC). The HMEC layer was covered by an agarose gel, upon which a Poly(lactic-co-glycolic acid)/CaP polymer with a Calcium-Phosphate (CaP) nanostructured surface was placed. This scaffold has already been shown to interact with endothelial cells and endothelial progenitor cells respectively in vivo. It was seeded with angiogenically stimulated (VEGF-A165) human CD14+ monocytes, to get a monocyte/macrophage fraction, which can promote angiogenesis, tissue remodelling and tissue repair due to the secretion of growth factors, cytokines, chemokines and enzymes. The study demonstrated that this assay is suitable to test angiogenic effects by stimulated human CD14+ monocytes on human microvascular endothelial cells influenced by Poly(lactic-co-glycolic acid)/CaP scaffolds with a nanostructured CaP surface. The assay can exclude effects on migration caused by gravity and also allows testing in a physiological environment on an extracellular matrix secreted by endothelial cells.
引用
收藏
页码:37 / 50
页数:14
相关论文
共 51 条
  • [1] Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO
  • [2] 2-J
  • [3] Alessandro R, 1996, IN VIVO, V10, P153
  • [4] Amorino GP, 1998, AM J PATHOL, V152, P199
  • [5] Angiogenesis assays: Problems and pitfalls
    Auerbach, R
    Akhtar, N
    Lewis, RL
    Shinners, BL
    [J]. CANCER AND METASTASIS REVIEWS, 2000, 19 (1-2) : 167 - 172
  • [6] Angiogenesis assays: A critical overview
    Auerbach, R
    Lewis, R
    Shinners, B
    Kubai, L
    Akhtar, N
    [J]. CLINICAL CHEMISTRY, 2003, 49 (01) : 32 - 40
  • [7] ASSAYS FOR ANGIOGENESIS - A REVIEW
    AUERBACH, R
    AUERBACH, W
    POLAKOWSKI, I
    [J]. PHARMACOLOGY & THERAPEUTICS, 1991, 51 (01) : 1 - 11
  • [8] UP-REGULATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION INDUCED BY MYOCARDIAL-ISCHEMIA - IMPLICATIONS FOR CORONARY ANGIOGENESIS
    BANAI, S
    SHWEIKI, D
    PINSON, A
    CHANDRA, M
    LAZAROVICI, G
    KESHET, E
    [J]. CARDIOVASCULAR RESEARCH, 1994, 28 (08) : 1176 - 1179
  • [9] Bando H, 2000, ADV EXP MED BIOL, V476, P267
  • [10] ACIDIFICATION OF PHAGOSOMES IN MURINE MACROPHAGES - BLOCKAGE BY NOCARDIA-ASTEROIDES
    BLACK, CM
    PALIESCHESKEY, M
    BEAMAN, BL
    DONOVAN, RM
    GOLDSTEIN, E
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1986, 154 (06) : 952 - 958